Keynote Lectures and Interviews:
The followings are the keynote lectures and interviews of the researchers working in the areas of ROS1+ lung cancer. It helped me to understand this disease tremendously. Hope it will help you.
*****************
This session is the talks given by the scientists on Targeted Oncology.
Alexander Drilon, MD and Justin Gainor, MD
Memorial Sloan Kettering Cancer Center and Massachusetts General Hospital
Aug 23, 2018
Sequencing therapy in ALK/ROS1-Rearraged NSCLC
ALK/ROS1-Rearranged NSCLC: Approaching Therapy
Emerging Predictive Biomarkers in NSCLC
Molecular Testing in Stage IV Lung Cancer
*****************
Bonnie J Addario Lung Cancer Foundation
August 6, 2018
Panel members are Dr. Ross Camidge, Dr. Chad Rusthoven and Dr. Dara Aisner and Janet Freeman-Daily. The Importance of a Multidisciplinary Team
https://www.facebook.com/pg/BJALCF/videos/
******************
Janet Freeman-Daily, Stage IV Lung Cancer Survivor; Patient Advocate
Programs featuring Janet Freeman-Daily
https://www.patientpower.info/bio/janet-freeman-daily
****************** In this section, new findings on ROS1+ NSCLC published from Colorado Cancer Blogs are summarized here.
Ross Camidge, MD, PhD
June 29, 2018
Dr. Camidge on the ALEX Trial in Patients With ALK+ NSCLC
Jun 2, 2018
Updated Phase 1 results of crizotinib against MET-amplified non-small cell lung cancer
http://www.coloradocancerblogs.org/updated-phase-1-results-of-crizotinib-against-met-amplified-non-small-cell-lung-cancer/
June 23, 2013
Dr. Camidge on Crizotinib as a ROS1 Inhibitor in NSCLC
Tejas Patil, MD
Jul 10, 2018 Brain metastases common and difficult to treat in ROS1 lung cancer, http://www.coloradocancerblogs.org/brain-metastases-common-and-difficult-to-treat-in-ros1-lung-cancer/
Robert C. Doebele, MD, PhD
Apr 10, 2018 Two Colorado studies find resistance mechanisms in ALK+ and ROS1+ cancers, http://www.coloradocancerblogs.org/two-colorado-studies-find-resistance-mechanisms-in-alk-and-ros1-cancers/
***************** Alice T. Shaw, MD PhD
March 29, 2018
Shaw Pattern of Resistance in ALK Positive NSCLC, YouTube.com/watch?v=59_6S2iD2lc
Feb 12, 2018
EML4/ALK and ROS-1: How do we sequence therapies, YouTube.com/watch?v=KTIMjRxEyhk
June 29, 2017
Q&A With Dr. Shaw: ALK/ROS1 cancertherapyadvisor.com/lung-can Inhibition in Patients With Non-small Cell Lung Cancer
cancertherapyadvisor.com/lung-cancer/alice-shaw-interview-lung-cancer-nsclc-alk-ros1-inhibition/article/672043/
June 14, 2017
Next generation of ALK TKI inhibitors for treatment of advanced ALK-positive NSCLC,
YouTube.com/watch?v=BPtm63O-kGc
Jan17, 2017
Discussion on Alectinib as First-Line Therapy in Lung Cancer, YouTube.com/watch?v=OymY4mUWTGs
Aug 19,2015
Targeted Therapies in Lung Cancer 2.0 – Advances and Promises,
YouTube.com/watch?v=OnHeM6x9TNc
March 10, 2014
Molecular Targetsin NSCLC, YouTube.com/watch/v=PUyUka7BaBg
Oct 28, 2013
ALK and ROS1 in Lung Cancer Next Generation Targeted Therapies
YouTube.com/watch?v=RwvCbZDDKmQ
July 19, 2013
Compares Crizotinib and Chemotherapy in NSCLC, YouTube.com/watch?v=qaGpLKG3zt8
Jan 21, 2013
Advances in Targeted Therapies for Lung Cancer, YouTube.com/watch/v=YdMRUjhBtbc
Oct 24, 2011
Targeting of NSCLC in 2011, YouTube.com/watch?v=XzBH70jgqQ
July 11, 2011
Koch Institute Delication Ceremony, YouTube.com/watch/v=f3aW1N90byk
*****************
Lecia V Sequist, MD, MPH
June 17, 2017
Diagnostic testing for genetic mutations in lung cancer, YouTube.com/watch?v=WjZbNF6jYVw
June 17, 2015
Understanding mutations in lung cancer, YouTube.com/watch?v=e9gTMptexi4
*******************
Prevailing with ROS1+ Lung Cancer 